Overexpression of muscle uncoupling protein 2 content in human obesity associates with reduced skeletal muscle lipid utilization

Jean Aimé Simoneau, David E. Kelley, Maria Neverova, Craig H Warden

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Uncoupling proteins (UCP) may influence thermogenesis. Since skeletal muscle plays an important role in energy homeostasis and substrate oxidation, this study was undertaken to test the hypotheses that skeletal muscle UCP2 content is altered in obesity and could be linked to basal energy expenditure, insulin sensitivity, or substrate oxidation within skeletal muscle under postabsorptive (fasting) conditions. To examine these possibilities, limb basal energy expenditure and respiratory quotient (bRQ) were measured in 18 obese nondiabetic (Ob) and lean individuals (L). Total body fat (%) ranged from 11% to 46%. In addition, insulin-stimulated rates of glucose disposal (Rd) were measured trader euglycemic hyperinsulinemic conditions. Biopsy of vastus lateralis muscle was used to measure cytochrome c oxidase (COX) enzyme activity and UCP2 content. Whereas low muscle COX activity was found in the Ob compared to L (6.9±1.6 vs. 9.6±1.2 U/g; P<0.001), skeletal muscle UCP2 content in Ob was significantly higher than in L (48±9 vs. 33±12 arbitrary units/g; P<0.05). Moreover, UCP2 content was positively correlated with percent of total body fat (r=0.57; P<0.05) and bRQ (r=0.59; P<0.01), but not with visceral fat (r=0.17; P=0.49), basal energy expenditure (r=0.07; P=0.79) or Rd (r=-0.23; P=-0.34). In summary, these results indicate that if development of obesity in humans is mediated by defective expression of UCP2 within skeletal muscle, then this effect is not observed in people with established obesity. The present study also suggests that skeletal muscle UCP2 content is not related to basal energy expenditure or insulin sensitivity in humans. However, the increased content of UCP2 within skeletal muscle in obesity appears to coincide with a reduced postabsorptive lipid utilization by muscle.

Original languageEnglish (US)
Pages (from-to)1739-1745
Number of pages7
JournalFASEB Journal
Volume12
Issue number15
StatePublished - 1998

Fingerprint

Muscle Proteins
muscle protein
Muscle
skeletal muscle
Skeletal Muscle
obesity
Obesity
Lipids
energy expenditure
Energy Metabolism
lipids
Proteins
insulin resistance
Muscles
muscles
body fat
Insulin Resistance
Adipose Tissue
Fats
Insulin

Keywords

  • Body fat
  • Energy expenditure
  • Insulin sensitivity
  • Substrate utilization
  • UCP

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Overexpression of muscle uncoupling protein 2 content in human obesity associates with reduced skeletal muscle lipid utilization. / Simoneau, Jean Aimé; Kelley, David E.; Neverova, Maria; Warden, Craig H.

In: FASEB Journal, Vol. 12, No. 15, 1998, p. 1739-1745.

Research output: Contribution to journalArticle

Simoneau, Jean Aimé ; Kelley, David E. ; Neverova, Maria ; Warden, Craig H. / Overexpression of muscle uncoupling protein 2 content in human obesity associates with reduced skeletal muscle lipid utilization. In: FASEB Journal. 1998 ; Vol. 12, No. 15. pp. 1739-1745.
@article{c1b593e2665f4267852a443e93fe5911,
title = "Overexpression of muscle uncoupling protein 2 content in human obesity associates with reduced skeletal muscle lipid utilization",
abstract = "Uncoupling proteins (UCP) may influence thermogenesis. Since skeletal muscle plays an important role in energy homeostasis and substrate oxidation, this study was undertaken to test the hypotheses that skeletal muscle UCP2 content is altered in obesity and could be linked to basal energy expenditure, insulin sensitivity, or substrate oxidation within skeletal muscle under postabsorptive (fasting) conditions. To examine these possibilities, limb basal energy expenditure and respiratory quotient (bRQ) were measured in 18 obese nondiabetic (Ob) and lean individuals (L). Total body fat ({\%}) ranged from 11{\%} to 46{\%}. In addition, insulin-stimulated rates of glucose disposal (Rd) were measured trader euglycemic hyperinsulinemic conditions. Biopsy of vastus lateralis muscle was used to measure cytochrome c oxidase (COX) enzyme activity and UCP2 content. Whereas low muscle COX activity was found in the Ob compared to L (6.9±1.6 vs. 9.6±1.2 U/g; P<0.001), skeletal muscle UCP2 content in Ob was significantly higher than in L (48±9 vs. 33±12 arbitrary units/g; P<0.05). Moreover, UCP2 content was positively correlated with percent of total body fat (r=0.57; P<0.05) and bRQ (r=0.59; P<0.01), but not with visceral fat (r=0.17; P=0.49), basal energy expenditure (r=0.07; P=0.79) or Rd (r=-0.23; P=-0.34). In summary, these results indicate that if development of obesity in humans is mediated by defective expression of UCP2 within skeletal muscle, then this effect is not observed in people with established obesity. The present study also suggests that skeletal muscle UCP2 content is not related to basal energy expenditure or insulin sensitivity in humans. However, the increased content of UCP2 within skeletal muscle in obesity appears to coincide with a reduced postabsorptive lipid utilization by muscle.",
keywords = "Body fat, Energy expenditure, Insulin sensitivity, Substrate utilization, UCP",
author = "Simoneau, {Jean Aim{\'e}} and Kelley, {David E.} and Maria Neverova and Warden, {Craig H}",
year = "1998",
language = "English (US)",
volume = "12",
pages = "1739--1745",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "15",

}

TY - JOUR

T1 - Overexpression of muscle uncoupling protein 2 content in human obesity associates with reduced skeletal muscle lipid utilization

AU - Simoneau, Jean Aimé

AU - Kelley, David E.

AU - Neverova, Maria

AU - Warden, Craig H

PY - 1998

Y1 - 1998

N2 - Uncoupling proteins (UCP) may influence thermogenesis. Since skeletal muscle plays an important role in energy homeostasis and substrate oxidation, this study was undertaken to test the hypotheses that skeletal muscle UCP2 content is altered in obesity and could be linked to basal energy expenditure, insulin sensitivity, or substrate oxidation within skeletal muscle under postabsorptive (fasting) conditions. To examine these possibilities, limb basal energy expenditure and respiratory quotient (bRQ) were measured in 18 obese nondiabetic (Ob) and lean individuals (L). Total body fat (%) ranged from 11% to 46%. In addition, insulin-stimulated rates of glucose disposal (Rd) were measured trader euglycemic hyperinsulinemic conditions. Biopsy of vastus lateralis muscle was used to measure cytochrome c oxidase (COX) enzyme activity and UCP2 content. Whereas low muscle COX activity was found in the Ob compared to L (6.9±1.6 vs. 9.6±1.2 U/g; P<0.001), skeletal muscle UCP2 content in Ob was significantly higher than in L (48±9 vs. 33±12 arbitrary units/g; P<0.05). Moreover, UCP2 content was positively correlated with percent of total body fat (r=0.57; P<0.05) and bRQ (r=0.59; P<0.01), but not with visceral fat (r=0.17; P=0.49), basal energy expenditure (r=0.07; P=0.79) or Rd (r=-0.23; P=-0.34). In summary, these results indicate that if development of obesity in humans is mediated by defective expression of UCP2 within skeletal muscle, then this effect is not observed in people with established obesity. The present study also suggests that skeletal muscle UCP2 content is not related to basal energy expenditure or insulin sensitivity in humans. However, the increased content of UCP2 within skeletal muscle in obesity appears to coincide with a reduced postabsorptive lipid utilization by muscle.

AB - Uncoupling proteins (UCP) may influence thermogenesis. Since skeletal muscle plays an important role in energy homeostasis and substrate oxidation, this study was undertaken to test the hypotheses that skeletal muscle UCP2 content is altered in obesity and could be linked to basal energy expenditure, insulin sensitivity, or substrate oxidation within skeletal muscle under postabsorptive (fasting) conditions. To examine these possibilities, limb basal energy expenditure and respiratory quotient (bRQ) were measured in 18 obese nondiabetic (Ob) and lean individuals (L). Total body fat (%) ranged from 11% to 46%. In addition, insulin-stimulated rates of glucose disposal (Rd) were measured trader euglycemic hyperinsulinemic conditions. Biopsy of vastus lateralis muscle was used to measure cytochrome c oxidase (COX) enzyme activity and UCP2 content. Whereas low muscle COX activity was found in the Ob compared to L (6.9±1.6 vs. 9.6±1.2 U/g; P<0.001), skeletal muscle UCP2 content in Ob was significantly higher than in L (48±9 vs. 33±12 arbitrary units/g; P<0.05). Moreover, UCP2 content was positively correlated with percent of total body fat (r=0.57; P<0.05) and bRQ (r=0.59; P<0.01), but not with visceral fat (r=0.17; P=0.49), basal energy expenditure (r=0.07; P=0.79) or Rd (r=-0.23; P=-0.34). In summary, these results indicate that if development of obesity in humans is mediated by defective expression of UCP2 within skeletal muscle, then this effect is not observed in people with established obesity. The present study also suggests that skeletal muscle UCP2 content is not related to basal energy expenditure or insulin sensitivity in humans. However, the increased content of UCP2 within skeletal muscle in obesity appears to coincide with a reduced postabsorptive lipid utilization by muscle.

KW - Body fat

KW - Energy expenditure

KW - Insulin sensitivity

KW - Substrate utilization

KW - UCP

UR - http://www.scopus.com/inward/record.url?scp=0031788924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031788924&partnerID=8YFLogxK

M3 - Article

C2 - 9837864

AN - SCOPUS:0031788924

VL - 12

SP - 1739

EP - 1745

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 15

ER -